March 22, 2018 / 12:22 PM / 5 months ago

BRIEF-Health Canada Accepts Cardiome's Xydalba For Review

March 22 (Reuters) - Cardiome Pharma Corp:

* HEALTH CANADA ACCEPTS CARDIOME’S XYDALBA NEW DRUG SUBMISSION AND GRANTS PRIORITY REVIEW

* CARDIOME PHARMA CORP - EXPECTS TO RECEIVE AN APPROVAL DECISION FOR XYDALBA DURING Q3 OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below